Longterm Follow-up of Subjects Treated With bb2121

Clinical trial NCT02786511 · COMPLETED

Trial details

NCT number: NCT02786511
Sponsor: Celgene
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Myeloma

Start date: 2016-04-28
Primary completion: 2019-10-11
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.